Prosecution Insights
Last updated: August 18, 2026

Examiner: WHALEY, PABLO S

Tech Center 3600 • Art Units: 1631 1684 3619

This examiner grants 25% of resolved cases

Performance Statistics

25.3%
Allow Rate
-26.7% vs TC avg
585
Total Applications
+21.3%
Interview Lift
1902
Avg Prosecution Days
Based on 530 resolved cases, 2023–2026

Rejection Statute Breakdown

28.6%
§101 Eligibility
4.8%
§102 Novelty
25.3%
§103 Obviousness
32.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17661674 ADAPTIVE SIGNAL PROCESSING Non-Final OA Medtronic MiniMed, Inc.
17616494 Likelihood Ratios for Out-of-Distribution Detection Final Rejection Google LLC
17764074 RANKING NEOANTIGENS FOR PERSONALIZED CANCER VACCINE Final Rejection Amazon Technologies, Inc.
17905250 Systems and Methods for Determining Spatial Accumulation of Signaling Molecules Within Tissue Samples Non-Final OA The Board of Trustees of the Leland Stanford Junior University
17718255 METHODS AND SYSTEMS FOR IDENTIFYING A DRUG MECHANISM OF ACTION USING NETWORK DYSREGULATION Final Rejection The Trustees of Columbia University in the City of New York
17696102 MACHINE LEARNING TO CORRECT FOR NONPHOTOCHEMICAL QUENCHING IN HIGH-FREQUENCY, IN VIVO FLUOROMETER DATA Final Rejection Rensselaer Polytechnic Institute
17681350 CONTROL METHOD FOR SPECIMEN ANALYSIS SYSTEM, SPECIMEN ANALYSIS SYSTEM, COMPUTER, AND PROGRAM Non-Final OA SYSMEX CORPORATION
17968285 OPTIMIZED BURDEN TEST BASED ON NESTED T-TESTS THAT MAXIMIZE SEPARATION BETWEEN CARRIERS AND NON-CARRIERS Non-Final OA ILLUMINA, INC.
18130134 METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR EVALUATING VARIANT LIKELIHOOD Non-Final OA LIFE TECHNOLOGIES CORPORATION
17136800 SYSTEMS AND METHODS FOR MAPPING SEQUENCE READS Non-Final OA LIFE TECHNOLOGIES CORPORATION
17769486 SYSTEMS AND METHODS FOR DETECTING A DISEASE CONDITION Non-Final OA Icahn School of Medicine at Mount Sinai
17428669 IDENTIFYING RESPONSIVENESS TO RADIO-IMMUNO COMBINATION THERAPY Non-Final OA Elekta, Inc.
18040108 SYSTEMS, METHODS, AND MEDIA FOR DETERMINING RELATIVE QUALITY OF OLIGONUCLEOTIDE PREPARATIONS Final Rejection Arc Bio, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month